Joseph Edelman
Vermögen: - $ am 30.09.2026
Vermögen: - $ am 30.09.2026
Joseph Eric Edelman is the founder of Perceptive Advisors LLC, founded in 1999, serving as Chief Executive Officer & Portfolio Manager.
Mr. Edelman is the founder of Perceptive Advisors (Private Equity), founded in 1999, serving as Portfolio Manager.
Mr. Edelman is the founder of ARYA Sciences Acquisition Corp., founded in 2018, serving as Chairman.
Mr. Edelman is the founder of ARYA Sciences Acquisition Corp.
IV, founded in 2020, serving as Chairman.
Mr. Edelman is the founder of ARYA Sciences Acquisition Corp.
V, founded in 2021, serving as Chairman.
Mr. Edelman is the founder of ARYA Sciences Acquisition Corp.
III, founded in 2020, serving as Chairman.
Mr. Edelman is the founder of ARYA Sciences Acquisition Corp.
II, founded in 2020, serving as Chairman.
Mr. Edelman was the founder of Perceptive Capital Solutions Corp., founded in 2024, serving as Chairman.
Current jobs include Independent Director at LeonaBio, Inc. since 2020, Director at Xontogeny LLC, Director at New York Genome Center, and Trustee at Brown University.
Former jobs include Director at Penwest Pharmaceuticals Co. from 2009 to 2010, Senior Analyst at Paramount BioCapital Asset Management, Inc., Senior Biotechnology Analyst at Prudential Securities, and Biotechnology Analyst at Martin Simpson & Co., Inc. Education includes an MBA from The Leonard N Stern School of Business in 1987 and an undergraduate degree from the University of California San Diego in 1979.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 23.06.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LEONABIO, INC. | Direktor/Vorstandsmitglied | 01.05.2020 |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Vorstandsvorsitzender | 01.01.1999 |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Direktor/Vorstandsmitglied | - |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Direktor/Vorstandsmitglied | - |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Vorstandsvorsitzender | 01.01.1999 |
| Unternehmen | Position | Ende |
|---|---|---|
| ARYA SCIE | Gründer | 01.08.2024 |
| ARYA SCIENCES ACQUISITION CORP V | Gründer | 01.07.2023 |
| ARYA SCIENCES ACQUISITION III A | Gründer | 01.06.2021 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 17 |
|---|---|
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Paramount BioCapital Asset Management manages hedge funds and private equity funds that focus on investments in healthcare and life sciences companies. The firm invests globally, with emphasis on the stocks of small-cap healthcare technology companies. | Finance |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Prudential Securities
Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
LeonaBio, Inc.
LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Martin Simpson & Co., Inc. | |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
ARYA Sciences Acquisition Corp.
ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. II
ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. III
ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. IV
ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. V
ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen